Skip to content
← Survival collections

CANCER EVIDENCE

Recent Trends

61 published cancer groups · 32,760 source series. Choose a group to explore its populations.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Source table

Published values for each cancer group are on that group page. This release supplies the source and dates.

Source
SEER
Table
Recent Trends
Data submission
November 2025 submission
Application release
Updated
June 22, 2026
Acquired

Acute Lymphocytic Leukemia (ALL)

144 source series

→

Acute Monocytic Leukemia (AML-M5)

144 source series

→

Acute Myeloid Leukemia (AML)

144 source series

→

Adenocarcinoma of the Esophagus

720 source series

→

Adenocarcinoma of the Lung and Bronchus

720 source series

→

All Cancer Sites Combined

144 source series

→

Anus, Anal Canal & Anorectum

720 source series

→

Bones and Joints

720 source series

→

Brain and Other Nervous System

720 source series

→

Breast

480 source series

→

Cervix Uteri

240 source series

→

Chronic Lymphocytic Leukemia (CLL)

144 source series

→

Chronic Myeloid Leukemia (CML)

144 source series

→

Colon (including Appendix)

720 source series

→

Colon and Rectum (excluding Appendix)

144 source series

→

Colon and Rectum (including Appendix)

720 source series

→

Corpus and Uterus, NOS

240 source series

→

Diffuse Astrocytoma and Anaplastic Astrocytoma of the Brain and ONS

720 source series

→

Embryonal Tumors of the Brain and ONS

660 source series

→

Esophagus

720 source series

→

Eye and Orbit

720 source series

→

Follicular Subtype of the Thyroid

720 source series

→

Gallbladder

720 source series

→

Glioblastoma of the Brain and ONS

720 source series

→

Hodgkin Lymphoma

720 source series

→

HR-/HER2- Breast Cancer (Female only)

48 source series

→

HR-/HER2+ Breast Cancer (Female only)

48 source series

→

HR+/HER2- Breast Cancer (Female only)

48 source series

→

HR+/HER2+ Breast Cancer (Female only)

48 source series

→

Kaposi Sarcoma

716 source series

→

Kidney

720 source series

→

Kidney and Renal Pelvis

720 source series

→

Large Cell Carcinoma of the Lung and Bronchus

720 source series

→

Larynx

720 source series

→

Leukemia

144 source series

→

Liver and Intrahepatic Bile Duct

720 source series

→

Lung and Bronchus

720 source series

→

Melanoma of the Skin

720 source series

→

Meningioma of the Brain and ONS

720 source series

→

Mesothelioma

720 source series

→

Myeloma

712 source series

→

Non-Hodgkin Lymphoma

720 source series

→

Oral Cavity and Pharynx

720 source series

→

Other Glioma of the Brain and ONS

720 source series

→

Ovary

240 source series

→

Pancreas

720 source series

→

Papillary Subtype of the Thyroid

720 source series

→

Prostate

240 source series

→

Rectum

720 source series

→

Renal Pelvis

720 source series

→

Small cell carcinoma of the Lung and Bronchus

720 source series

→

Small Intestine

720 source series

→

Soft Tissue including Heart

720 source series

→

Squamous Cell Carcinoma of the Esophagus

720 source series

→

Squamous Cell Carcinoma of the Lung and Bronchus

720 source series

→

Stomach

720 source series

→

Testis

48 source series

→

Thyroid

720 source series

→

Urinary Bladder (Invasive & In Situ)

720 source series

→

Vagina

240 source series

→

Vulva

240 source series

→
Recent Trends · SEER cancer survival | Triangle